These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 35970191

  • 1. [Keratoprostheses: Last Hope for the Most Severe Corneal Diseases].
    Bachmann B, Schaub F, Cursiefen C.
    Klin Monbl Augenheilkd; 2022 Sep; 239(9):1165-1179. PubMed ID: 35970191
    [Abstract] [Full Text] [Related]

  • 2. Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.
    Bakshi SK, Graney J, Paschalis EI, Agarwal S, Basu S, Iyer G, Liu C, Srinivasan B, Chodosh J.
    Cornea; 2020 Apr; 39(4):484-490. PubMed ID: 31724985
    [Abstract] [Full Text] [Related]

  • 3. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R, Khoueir Z, Tsikata E, Chodosh J, Dohlman CH, Chen TC.
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The Boston keratoprosthesis in the management of corneal blindness: Indications and limitations].
    Stolowy N, Callet M, Beylerian M, Hoffart L, Yin GHW.
    J Fr Ophtalmol; 2018 Sep; 41(7):642-649. PubMed ID: 30170706
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Boston keratoprosthesis type I in the elderly.
    Homayounfar G, Grassi CM, Al-Moujahed A, Colby KA, Dohlman CH, Chodosh J.
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical outcomes and significance of postoperative ultrasound biomicroscopy in patients with Boston type 1 keratoprosthesis.
    Tas AY, Abay B, Muftuoglu O.
    Arq Bras Oftalmol; 2024 Apr; 88(1):e20230160. PubMed ID: 39109743
    [Abstract] [Full Text] [Related]

  • 10. The historical development and an overview of contemporary keratoprostheses.
    Moshirfar M, Moody JJ, Barke MR, Martheswaran T, Thomson AC, Thomson RJ, Somani SN, Shmunes KM, Ronquillo YC, Hoopes P.
    Surv Ophthalmol; 2022 Apr; 67(4):1175-1199. PubMed ID: 35081413
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vitreoretinal aspects of permanent keratoprosthesis.
    Klufas MA, Yannuzzi NA, D'Amico DJ, Kiss S.
    Surv Ophthalmol; 2015 Apr; 60(3):216-28. PubMed ID: 25890625
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K, Yu F, Aldave AJ.
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [Abstract] [Full Text] [Related]

  • 17. Challenges in management of the Boston Keratoprosthesis Type 1.
    Koo EH, Hannush SB.
    Curr Opin Ophthalmol; 2021 Jul 01; 32(4):385-388. PubMed ID: 33973907
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.